Dergiler / İstanbul Medical Journal / 2022 / Cilt: 23 - Sayı: 1

The Association Between Arg72Pro C>G Polymorphism in the p53 Gene and the Risk of Obesity

Sayfa
55–59
Yayın Tarihi
2022-10-19
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Further research is needed in a large cohort to associate the p53 gene Arg72Pro C>G (rs1042522) variant with obesity risk.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Introduction: The role of genetic factors in obesity has long been recognized, but their involved specific genes remained unidentified.
📊
Temel Bulgular & Veri:The relationship between p53 gene single nucleotide polymorphisms and the risk of obesity has been investigated in recent years.
💡
Sonuç & Katkı:Further research is needed in a large cohort to associate the p53 gene Arg72Pro C>G (rs1042522) variant with obesity risk.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Introduction: The role of genetic factors in obesity has long been recognized, but their involved specific genes remained unidentified. The relationship between p53 gene single nucleotide polymorphisms and the risk of obesity has been investigated in recent years. Therefore, this study aimed to investigate the association of p53 Arg72Pro C>G (rs1042522) polymorphism with the risk of obesity in our study. Methods: This study included 52 patients with obesity (26 were females and 26 were males) and 52 normal-weight healthy controls. Genomic DNA isolation was performed from the blood samples of all participants. P53 Arg72Pro C>G (rs1042522) polymorphism was detected by real-time quantitative polymerase chain reaction from genomic DNA samples. Results: No significant associations were identified between Arg72Pro (rs1042522) P53 polymorphism and obesity risk. Glucose levels are significantly different between the obese and control groups with the CC and CG genotypes, but without difference in the GG homozygous genotype. Conclusion: Our study is one of the first to investigate the relationship between p53 codon 72 polymorphisms and obesity risk but revealed no correlation between them. The relatively small number of participants may limit our study. Further research is needed in a large cohort to associate the p53 gene Arg72Pro C>G (rs1042522) variant with obesity risk.

🔖

Bu Makaleye Atıf Yap

KOÇ, G., SOYOCAK, A., ALIŞ, H., KAYA, Z. (2022). The Association Between Arg72Pro C>G Polymorphism in the p53 Gene and the Risk of Obesity. İstanbul Medical Journal, Cilt: 23 - Sayı: 1, 55–59. https://ajindex.com/articles/551771

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. González-Muniesa P, Mártinez-González MA, Hu FB, Després JP, Matsuzawa Y, Loos RJF, et al. Obesity. Nat Rev Dis Primers 2017; 3: 17034
  2. Wright SM, Aronne LJ. Causes of obesity. Abdom Imaging 2012; 37: 730-2
  3. Zwezdaryk K, Sullivan D, Saifudeen Z. The p53/Adipose-Tissue/ Cancer Nexus. Front Endocrinol (Lausanne) 2018; 9: 457
  4. Strycharz J, Drzewoski J, Szemraj J, Sliwinska A. Is p53 Involved in Tissue-Specific Insulin Resistance Formation? Oxid Med Cell Longev 2017; 2017: 9270549
  5. Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res 2004; 64: 2627-33
  6. Goldstein I, Rotter V. Regulation of lipid metabolism by p53 - fighting two villains with one sword Trends Endocrinol Metab 2012; 23: 567- 75
  7. Molchadsky A, Ezra O, Amendola PG, Krantz D, Kogan-Sakin I, Buganim Y, et al. p53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity. Cell Death Differ 2013; 20: 774-83
  8. Gloria-Bottini F, Banci M, Saccucci P, Magrini A, Bottini E. Is there a role of p53 codon 72 polymorphism in the susceptibility to type 2 diabetes in overweight subjects? A study in patients with cardiovascular diseases. Diabetes Res Clin Pract 2011; 91: e64-e67
  9. Chen RH, Chang CT, Wang TY, Huang WL, Tsai CH, Tsai FJ. p53 codon 72 proline/arginine polymorphism and autoimmune thyroid diseases. J Clin Lab Anal 2008; 22: 321-6
  10. Pim D, Banks L. p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 2004; 108: 196-9
  11. Burgdorf KS, Grarup N, Justesen JM, Harder MN, Witte DR, Jorgensen T, et al. Studies of the association of Arg72Pro of tumor suppressor protein p53 with type 2 diabetes in a combined analysis of 55,521 Europeans. PLoS One 2011; 6: e15813
  12. Marin MC, Jost CA, Brooks LA, Irwin MS, O’Nions J, Tidy JA, et al. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet 2000; 25: 47-54
  13. Sabir JSM, El Omri A, Shaik NA, Banaganapalli B, Hajrah NH, Zrelli H, et al. The genetic association study of TP53 polymorphisms in Saudi obese patients. Saudi J Biol Sci 2019; 26: 1338-43
  14. Kodal JB, Vedel-Krogh S, Kobylecki CJ, Nordestgaard BG, Bojesen SE. TP53 Arg72Pro, mortality after cancer, and all-cause mortality in 105,200 individuals. Sci Rep 2017; 7: 336
  15. Sakamuro D, Sabbatini P, White E, Prendergast GC. The polyproline region of p53 is